Understanding heparin-induced thrombosis: A brief review
Heparin has been the first line for treatment and prevention of thrombosis for a while. However, one of its non-hemorrhagic effects remains noticeable: heparin-induced thrombocytopenia, mediated by antibodies directed to complexes of platelet factor, and heparin. Binding to platelet FcγRIIA receptor...
Guardado en:
Autores principales: | Mariela Irabien-Zúñiga, Edgar A. Rojas-Guerrero, David Gómez-Almaguer |
---|---|
Formato: | article |
Lenguaje: | EN ES |
Publicado: |
Permanyer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b10f43abc7545de8c709f8758e13e78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Convalescent plasma therapy in patients with coronavirus disease-19 – One year after: A brief review
por: Mariela Irabien-Zúñiga, et al.
Publicado: (2021) -
Oral contraceptive consumption and cerebral venous sinuses thrombosis
por: Jha Gupta Kukum, et al.
Publicado: (2016) -
Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
por: Harry Menon, et al.
Publicado: (2018) -
COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis
por: Clio Bilotta, et al.
Publicado: (2021) -
Rivaroxaban para el tratamiento de la trombocitopenia inducida por heparina. Caso clínico
por: Rivera O.,Gustavo, et al.
Publicado: (2017)